Source: PharmiWeb

Alcyonels: Alcyone Lifesciences Announces the Use of AMC Intratumoral Delivery Platform in the Treatment of First Patient in DNX-2440 Glioblastoma Trial

Alcyone Lifesciences Announces the Use of AMC Intratumoral Delivery Platform in the Treatment of First Patient in DNX-2440 Glioblastoma Tri...Alcyone Lifesciences, Inc.

Read full article »
Alcyonels's Competitors | Alcyonels's News | Alcyonels's Financials
Stay up-to-date with the latest news on Alcyone Lifesciences, Inc.
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
PJ Anand's photo - President & CEO of Alcyone Lifesciences, Inc.

President & CEO

PJ Anand

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on Alcyone Lifesciences, Inc.